A nasal vaccine for COVID-19 – based on technology developed at Washington University in St. Louis – is poised to enter a phase 1 clinical trial in the U.S. after an investigational new drug ...

The first participants in an international clinical trial aimed at preventing Alzheimer's disease in young adults at high risk of the disease have been enrolled.

Washington Commanders controlling owner Josh Harris says the team name is not changing. Harris said the name is here to stay after inheriting it when he and his group bought the team from longtime ...